Water Soluble Tetrazolium Salt-11 as an Alternative to Riboflavin for Corneal Collagen Cross-linking for the Treatment of Keratoconus
Adel Barbara, Ramez Barbara, Sajjad Abbas
Citation Information :
Barbara A, Barbara R, Abbas S. Water Soluble Tetrazolium Salt-11 as an Alternative to Riboflavin for Corneal Collagen Cross-linking for the Treatment of Keratoconus. Int J Kerat Ect Cor Dis 2017; 6 (1):42-44.
Abbas S, Barbara R, Barbara A. Water Soluble Tetrazolium Salt-11 as an Alternative to Riboflavin for Corneal Collagen Cross-linking for the Treatment of Keratoconus. Int J Kerat Ect Cor Dis 2017;6(1):42-44.
Riboflavin/ultraviolet- A-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 2003 May;135(5):620-627.
Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol 2006 Aug;17(4):356-360.
Contemporary treatment paradigms in keratoconus. Cornea 2015 Oct;34(Suppl 10): S16-S23.
Safety of UVA-riboflavin cross-linking of the cornea. Cornea 2007 May;26(4):385-389.
Corneal collagen cross-linking with and without epithelial removal: a contralateral study with 0.5% hypotonic riboflavin solution. BioMed Res Int 2014;2014:1-9.
Corneal crosslinking with riboflavin and ultraviolet A. I. Principles. Ocul Surf 2013 Apr;11(2): 65-74.
Lens densitometry after corneal cross-linking in patients with keratoconus using a Scheimpflug camera. J Ophthalmic Vis Res 2015 Apr-Jun;10(2):118-122.
WST11, a novel water-soluble bacteriochlorophyll derivative; cellular uptake, pharmacokinetics, biodistribution, and vascular targeted photodynamic activity against melanoma tumors. Photochem Photobiol 2005 Mar-Apr;81(2):342-351.
Novel water-soluble bacteriochlorophyll derivatives for vascular-targeted photodynamic therapy: synthesis, solubility, phototoxicity, and the effect of serum proteins. Photochem Photobiol 2005 Jul-Aug;81(4):983-993.
Photocatalytic generation of oxygen radicals by the water-soluble bacteriochlorophyll derivative WST11, noncovalently bound to serum albumin. J Phys Chem A 2009 Jul;113(28):8027-8037.
Photodynamic therapy for prostate cancer – a review of current status and future promise. Nat Clin Pract Urol 2009 Jan;6(1):18-30.
Final results of a phase I/II multicenter trial of WST11 vascular targeted photodynamic therapy for hemi-ablation of the prostate in men with unilateral low risk prostate cancer performed in the United States. J Urol 2016 Oct;196(4):1096-1104.
Treatment of localized prostate cancer using WST-09 and WST-11 mediated vascular targeted photodynamic therapy – a review. Photodiagn Photodyn Ther 2015 Dec;12(4):567-574.
Traitement des cancers localisés de la prostate par photothérapie dynamique. Prog Urol 2014;24(14):911-914.
Nonthermal ablation by using intravascular oxygen radical generation with WST11: dynamic tissue effects and implications for focal therapy. Radiology 2016 Oct:141571.
Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes. Invest Ophthalmol Vis Sci 2008 Apr;49(4):1633-1644.
Stiffening of rabbit corneas by the bacteriochlorophyll derivative WST11 using near infrared light. Invest Ophthalmol Vis Sci 2012 Sep;53(10):6378-6388.
Collagen corneal cross-linking and the epithelium. Int J Kerat Ect Cor Dis 2012;1(3):179-184.
